Indian shares swing between gains and losses; head for weekly fall

By: |
Updated: Dec 16, 2016 3:33 PM

Indian shares swung between gains and losses on Friday as markets looked to settle down after the US Federal Reserve issued an outlook that was more hawkish than expected, though indexes were still poised to post their biggest weekly fall in a month.

Indian stock markets look more vulnerable than other emerging markets due to the ongoing demonetisation drive and its possible heavy impact on corporate performances. (Source: PTI)

Indian shares swung between gains and losses on Friday as markets looked to settle down after the US Federal Reserve issued an outlook that was more hawkish than expected, though indexes were still poised to post their biggest weekly fall in a month.

As the dollar stood near a 14-year peak, global markets continued to adjust to the idea of higher US interest rates after the Fed raised rates on Wednesday for the first time in a year and projected three more increases in 2017, up from two forecast in September.

Indian stock markets look more vulnerable than other emerging markets due to the ongoing demonetisation drive and its possible heavy impact on corporate performances.

“The markets have become highly rangebound in the last one month or so. The Nifty is hardly moving in a 100-point range and the Sensex is moving in a 500-point range. This tight range will continue for some time,” said Kunj Bansal, chief investment officer, Centrum Wealth Management Ltd.

“The major triggers – the RBI credit policy and the US Fed decision – are over. Now, the next earliest trigger would be the earnings season, starting in the second week of January. Pending that, the market will remain rangebound.”

The broader NSE index was down 0.12 percent at 8,143.20 as of 0536 GMT, and has declined 1.5 percent so far this week, its biggest since the week ended on Nov. 18.

You may also like to watch this

The benchmark BSE index was 0.05 percent lower at 26,404.62, and has shed 0.95 percent so far this week.

Among decliners, Aurobindo Pharma Ltd’s shares fell as much as 4.34 percent to a nine-month low as the company was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly used drugs in the United States.

Other drug makers also fell on lingering concerns about potential action from the U.S. Food and Drug Administration. Sun Pharmaceutical Industries Ltd fell as much as 2.52 percent, while Alkem Laboratories Ltd declined up to 1.5 percent. (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Subhranshu Sahu)

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Rakesh Jhunjhunwala trimmed stake in these firms last quarter, shares of some have since gained
2NASDAQ 100 turns negative year-to-date, even FAANG stocks fall victim to bearish sentiment
3Sensex, Nifty end the week with gains despite hiccups; where will Dalal Street head to next?